Books by Subject
Infectious DiseasesAccess restricted to Stanford unless otherwise noted
- Achieving an AIDS transition 2011, ebraryThe global AIDS transition: a feasible objective for AIDS policy -- Using incentives to prevent HIV infections -- Sustaining and leveraging AIDS treatment -- Appendix A. Alternative approaches to estimating the average cost of antiretroviral treatment -- Appendix B. A meta-analysis of the health benefits of early initiation of antiretroviral therapy -- Appendix C. A model for projecting future AIDS treatment costs.
- Antimicrobial chemotherapy. 6th ed. / 2012, OvidPt. 1. General properties of antimicrobial agents -- Pt. 2. Resistance to antimicrobial agents -- Pt. 3. General principles of usage of antimicrobial agents -- Pt. 4. Therapeutic use of antimicrobial agents.
- Antimicrobial drug resistance v. 1-2, 2009., Springerv. 2, 2009 Springerv. 1. Mechanisms of drug resistance -- v. 2. Clinical and epidemiological aspects.
- Antimicrobial resistance 2010, KargerCommunity-associated methicillin resistant staphylococcus aureus / Miller, L.G. -- Infections with organisms producing extended-spectrum [beta]-lactamase / Paterson, D.L., Doi, Y. -- Fluoroquinolone resistance : challenges for disease control / Parry, C.M. -- Antibiotic resistance and community-acquired pneumonia during an influenza pandemic / Moore, M.R., Whitney, C.G. -- Promoting appropriate antimicrobial drug use in the outpatient setting : what works? / Belongia, E.A., Mangione-Smith, R., Knobloch, M.J. -- Reducing antimicrobial-resistant infections in health care settings : what works? / Rezai, K., Weinstein, R.A. -- Cost of antimicrobial resistance in healthcare settings : a critical review / Merz, L.R., Guth, R.M., Fraser, V.J. -- Mass treatment of parasitic disease : implications for the development and spread of anthelmintic resistance / Curcher, T.S. ... [et al.] -- Antifungal drug resistance : clinical importance, in vitro detection and implications for prophylaxis and treatment / Arthington-Skaggs, B.A., Frade, J.P. -- Preparing for HIV drug resistance in the developing world / Bennett, D.E.
- Mechanisms of resistance by gram-positive bacteria (streptococci and enterococci) /Javier Aspa Marco ... [et al.] --Emergence of MRSA in the community /Adam L. Cohen, Rachel Gorwitz, and Daniel B. Jernigan --Antimicrobial resistance to sexually transmitted infections /Hillard Weinstock, David Trees, and John Papp --Resistance of gram-negative bacilli to antimicrobials /Patricia A. Bradford and Charles R. Dean --Mycobacterial antimicrobial resistance /Peter D.O. Davies and Richard Cooke --Antimicrobial resistance of anaerobic bacteria /Ellie J.C. Goldstein, Diane M. Citron, and David W. Hecht --Clinical significance and biological basis of HIV drug resistance /Jorge L. Martinez-Cajas, Marco Petrella, and Mark A. Wainberg --Resistance of herpesviruses to antiviral agents /G. Boivin and W.L. Drew --Hepatitis virus resistance /Jean-Michel Pawlotsky --Resistance to antifungal agents /Beth A. Arthington-Skaggs and John H. Rex --An anti-mutant approach for antimicrobial use /Karl Drlica ... [et al.]
- Antimicrobial resistance in developing countries 2010, SpringerGeneral issues in antimicrobial resistance -- Global perspectives of antibiotic resistance -- Mechanisms of antimicrobial resistance -- Poverty and root causes of resistance in developing countries -- What the future holds for resistance in developing countries -- Introduction of antimicrobial agents in resource-constrained countries: impact on the emergence of resistance -- Human impact of resistance -- Human immunodeficiency virus: resistance to antiretroviral drugs in developing countries -- Drug resistance in malaria in developing countries -- Drug resistance in Mycobacterium tuberculosis -- Antifungal drug resistance in developing countries -- Drug resistance in African trypanosomiasis -- Antimicrobial resistance in enteric pathogens in developing countries -- Bacterial-resistant infections in resource-limited countries -- Prevalence of resistant enterococci in developing countries -- Antimicrobial resistance in gram-negative bacteria from developing countries -- Resistance in reservoirs and human commensals -- Antimicrobial use and misuse -- Determinants of antimicrobial use: poorly understood-poorly researched -- Antimicrobial use and resistance in Africa -- Antimicrobial drug resistance in Asia -- Antimicrobial drug resistance in Latin American and the Caribbean -- Hospital infections by antimicrobial-resistant organisms in developing countries -- Cost, policy, and regulation of antimicrobials -- Economic burden of antimicrobial resistance in the developing world -- Strengthening health systems to improve access to antimicrobials and the containment of resistance -- Role of unregulated sale and dispensing of antimicrobial agents on the development of antimicrobial resistance in developing countries -- Counterfeit and substandard anti-infectives in developing countries -- Strategies to contain antimicrobial resistance -- Containment of antimicrobial resistance in developing countries and lessons learned -- Surveillance of antibiotic resistance in developing countries: needs, constraints and realities -- Vaccines: a cost-effective strategy to contain antimicrobial resistance -- Teaching appropriate antibiotic use in developing countries -- Containing global antibiotic resistance: ethical drug promotion in the developing world -- News media reporting of antimicrobial resistance in Latin America and India.
- Avian influenza 2008, KargerEpidemiology of avian influenza / Osterhaus, A.D.M.E., Munster, V.J., Fouchier, R.A.M. -- H5N1 in Asia / Yen, H.-L. ... [et al.] -- Epidemiology and control of H5N1 avian influenza in China / Chen, H., Bu, Z., Wang, J. -- Avian influenza in Northern Eurasia / Lvov, D.K., Kaverin, N.V. -- Avian influenza in Italy, 1997-2006 / Capua, I. ... [et al.] -- Avian influenza outbreaks in Germany : development of new avian vaccines / Werner, O. ... [et al.] -- The role of pigs in interspecies transmission / Brown, I.H. -- History of research on avian influenza / Scholtissek, C. -- Reverse genetics of influenza viruses : applications in research and vaccine design / Neumann, G., Horimoto, T., Kawaoka, Y. -- Receptor specificity of influenza viruses and its alteration during interspecies transmission / Matrosovich, M.N., Gambaryan, A.S., Klenk, H.-K. -- Cleavage activation of the influenza virus hemagglutinin and its role in pathogenesis / Garten, W., Klenk, H.-D. --Structure and function of the influenza A virus ribonucleoprotein : transcription and replication / Ortín, J. -- Influenza A virus polymerase : a determinant of host range and pathogenicity / Stech, J. -- Influenza A virus virulence and innate immunity : recent insights from new mouse models / Haller, O., Kochs, G., Staeheli, P. -- Signaling to life and death : influenza viruses and intracellular signal transduction cascades / Ludwig, S. ... [et al.] -- Cytokines in the pathogenesis of highly virulent influenza viruses in humans / Van Reeth, K. -- Antivirals and resistance / Hay, A.J., Collins, P.J., Russell, R.J. -- The 1918 influenza pandemic : lessons from the past raise questions for the future / Steel, J., Palese, P.
- Avian influenza and Newcastle disease 2009, Springer
- Bacterial genomes and infectious diseases 2006, SpringerMicrobial genomes / Voon Loong Chan -- Evolution and origin of virulence isolates / Voon Loong Chan, Philip M. Sherman, and Billy Bourke -- Genomic approach to understanding of infectious disease mechanisms / Voon Loong Chan, Philip M. Sherman, and Billy Bourke -- Knockout and disease models in toll-like receptor-mediated immunity / Huey-Lan Huang and Wen-Chen Yeh -- Campylobacter from glycome to pathogenesis / John Kelly ... [et al.] -- Genomics of helicobacter species / Zhongming Ge and David B. Schauer -- The organization of leptospira at a genomic level / Dieter M. Bulach ... [et al.] -- Listeria monocytogenes / Keith Ireton -- Mycobacterial genomes / David C. Alexander and Jun Liu -- Mycoplasma / Yuko Sasaki -- Genome comparisons of diverse staphylococcus aureus strains / Martin J. McGavin -- Type III secretion, systems in yersinia pestis, and yersinia pseudotuberculosis / James B. Bliska, Michelle B. Ryndak, and Jens P. Grabenstein -- Genomics and the evolution of pathogenic vibrio cholerae / William S. Jermyn ... [et al.] -- Future directions of infectious disease research / Philip M. Sherman, Billy Bourke, and Voon Loong Chan -- Index.
- Bacterial infections of humans. 4th ed. 2009, SpringerEpidemiological concepts / Alfred S. Evans -- Public health surveillance / Philip S. Brachman -- Molecular epidemiology / Lee W. Riley -- Epidemiology of bacterial resistance to antimicrobial agents / Fred C. Tenover and John E. McGowan, Jr. -- Anthrax / Philip S. Brachman and Arnold F. Kaufmann -- Bacterial foodborne disease / Heather Green ... [et al.] -- Botulism / Patricia A. Yu ... [et al.] -- Brucellosis / Edward J. Young -- Campylobacter infections / Ban Mishu Allos -- Chancroid / Jaffar A. Al-Tawfiq -- Chlamydial infections / Julius Schachter and E. Russell Alexander -- Cholera / Manoj P. Menon, Eric D. Mintz, and Robert V. Tauxe -- Clostridium difficile / Dale N. Gerding and Stuart Johnson -- Dipththeria / Melinda Wharton -- Escherichia coli diarrhea / Herbert L. DuPont, M. Teresa Estrada-Garcia, and Zhi-Dong Jiang -- Gonococcal infections / Jonathan M. Zenilman and J. McLeod Griffiss -- Haemophilus influenzae / Janet R. Gilsdorf -- Helicobacter pylori / Sharon Perry, Catherine de Martel, and Julie Parsonnet -- Legionellosis / Roopal Patel, Matthew R. Moore, and barry S. Fields -- Leprosy / Richard I. Frankel and David M. Scollard -- Leptospirosis / Paul N. Levett and Charles N. Edwards -- Listeria monocytogenes infections / Donald Armstrong and Donald B. Louria -- Lyme disease / Roger P. Clark and Linden T. Hu -- Meningococcal infections / Robert S. Baltimore -- Mycoplasma pneumoniae and other human mycoplasmas / Deborah F. Talkington and Ken B. Waites -- Healthcare-acquired bacterial infections / Ebbing Lautenbach and Elias Abrutyn -- Pertussis / Scott A. Halperin and Gaston De Serres -- Plague / David T. Dennis and J. Erin Staples -- Pneumococcal infections / Keith P. Klugman and Charles Feldman -- Q fever / Thomas J. Marrie -- Rocky mountain spotted fever / Aaron Milstone and J. Stephen Dumler -- Salmonellosis : nontyphoidal / Michael F. Lynch and Robert V. Tauxe -- Shigellosis / Gerald T. Keusch -- Evans' infections of humans: staphylococcal infections / Zeina A. Kanafani and Vance G. Fowler, Jr. -- Streptococcal infections / Barry M. Gray and Dennis L. Stevens -- Syphilis / Anne Rompalo and Willard Cates -- Nonvenereal treponematoses / Ammar M. Ahmed ... [et al.] -- Tetanus / Steven G.F. Wassilak and Katrina Kretsinger -- Toxic shock syndrome (staphylococcal) / Arthur L. Reingold -- Tuberculosis / Diana S. Pope, Richard E. Chaisson, and George W. Comstock -- Nontuberculous mycobacterial infections / Charles L. Daley -- Tularemia / Paul S. Mead and Jeannine M. Petersen -- Typhoid fever / Myron M. Levine -- Yersinia enterocolitica infections / Ann M. Schmitz and Robert V. Tauxe.
- Epidemiology of healthcare-associated infections -- The healthcare epidemiologist -- Hand hygiene -- Personnel health services -- The development of infection surveillance and control programs -- Surveillance of healthcare-associated infections -- Investigating endemic and epidemic healthcare-associated infections -- Epidemiological methods for investigating infections in the healthcare setting -- Use of computerized systems in healthcare epidemiology -- The role of the laboratory in control of healthcare-associated infections -- The practice of epidemiology in community hospitals -- The role of professional and regulatory organizations in infection control -- Antimicrobial stewardship: programmatic efforts to optimize antimicrobial use -- Multiply drug-resistant pathogens: epidemiology and control -- Molecular biology of resistance -- Economic evaluation of healthcare-associated infections and infection control interventions -- Legal aspects of healthcare-associated infections -- Infection control: a global view -- The inanimate environment -- Sterilization and disinfection -- Foodborne disease prevention in healthcare facilities -- Clinical laboratory-acquired infections -- Dialysis-associated complications and their control -- The intensive care unit: part A. HAI epidemiology, risk factors, surveillance, engineering and administrative infection control practices, and impact -- The intensive care unit: part B. antibiotic resistance and prevention of CVC-BSIs, catheter-associated urinary tract infections and C. difficile -- The newborn nursery and the neonatal intensive care unit -- The operating room -- Ambulatory care setting -- Infections in long-term care facilities -- Incidence and nature of endemic and epidemic healthcare-associated infections -- Urinary tract infections -- Hospital-acquired pneumonia -- Tuberculosis -- Infectious gastroenteritis -- Central nervous system infections -- Surgical site infections -- Infections of burn wounds -- Infections due to infusion therapy -- Infections of implantable cardiac and vascular devices -- Infections in skeletal prostheses -- The importance of infection control in controlling antimicrobial-resistant pathogens -- Healthcare-associated respiratory viral infections -- Blood borne pathogen prevention -- Healthcare-associated fungal infections -- Infection in transplant recipients -- Miscellaneous procedure-related infections -- Public reporting of healthcare-associated infection rates -- Patient safety.
- Biodefense 2006, CRCnetBASE
- Biofilms, infection, and antimicrobial therapy 2006, CRCnetBASEMicrobial biofilms / Xiuping Jiang and John L. Pace -- Economic impact of biofilms on treatment costs / John G. Thomas, Isaiah Litton, and Harald Rinde -- Biofilm-related indwelling medical device infections / Matthew K. Schinabeck and Mahmoud A. Ghannoum -- Medical device composition and biological secretion influences on biofilm formation / Sean P. Gorman and David S. Jones -- Role of biofilms in infections caused by Escherichia coli / Grégory Jubelin, Corinne Dorel, and Philippe Lejeune -- Staphylococcus aureus biofilms / Julie M. Higashi and Paul M. Sullam -- Coagulase-negative staphylococci / Dietrich Mach ... [et al.] -- Pseudomonas aeruginosa biofilm infections in cystic fibrosis / Andrea Smiley and Daniel J. Hassett -- Candida / Stephen Hawser and Khalid Islam -- Current perspectives on the regulation of the ica operon and biofilm formation in Staphylococcus epidermidis / Paul D. Fey and Luke D. Handke -- Cell-to-cell communication in bacteria / Kenneth D. Tucker and Luciano Passador -- Persisters: specialized cells responsible for biofilm tolerance to antimicrobial agents / Kim Lewis ... [et al.] -- Minimal biofilm eradication concentration (MBEC) assay: susceptibility testing for biofilms / Howard Ceri ... [et al.] -- Environmental cues regulate virulence and biofilm formation / John L. Pace and Steven M. Frey -- In vivo models for the study of biomaterial-associated infection by biofilm-forming staphylococci / Luke D. Handke and Mark E. Rupp -- Host response to biofilms / Susan Meier-Davis -- Pharmacodynamics and the treatment of IMD-related infections / Roger Finch and Sarah Gander -- Protein synthesis inhibitors, fluoroquinolones, and rifampin for biofilm infections / Steven L. Barriere -- [beta][beta]-lactams for the treatment of biofilm-associated infections / Ingrid L. Dodge, Karen Joy Shaw, and Karen Bush -- Glycopeptide antibacterials and the treatment of biofilm-related infections / John L. Pace, Roasaire Verna, and Jan Verhoef -- Antibiotic resistance in biofilms / Nafsika H. Georgopapadakou -- Treatment protocols for infections of vascular catheters / Russell E. Lewis and Issam I Raad -- Treatment protocols for bacterial endocarditis and infection of electrophysiologic cardiac devices / Martin E. Stryjewski and G. Ralph Corey -- Treatment protocol of infections of orthopedic devices / Vera Antonios, Elie Berbari, and Douglas Osmon.
- Biological threats and terrorism 2002, NAP
- Biological weapons defense 2005, SpringerDepartment of defense capabilities supporting bioterrorism response -- Modeling for bioterrorism incidents -- Biological weapons defense: effect levels -- Pathogenesis by aerosol -- Bacillus anthracis and the pathogenesis of anthrax -- Virologic and pathogenic aspects of the variola virus (Smallpox) as a bioweapon -- Plague vaccines: retrospective analysis and future developments -- Medical protection against brucellosis -- Pathogenesis of and immunity to coxiella burnetii -- Glanders: new insights into an old disease -- Medical countermeasures for filoviruses and other viral agents -- Medical defense against protein toxin weapons: review and perspective -- Antimicrobials for biological warfare agents -- Nonspecific immunomodulator therapy: CpG -- Decontamination -- Definition and overview of emerging threats -- Department of defense global emerging infections system programs in biodefense -- Information resources and database development for defense against biological weapons -- Genomic efforts with biodefense pathogens -- Genomics for biodefense: exploiting the francisella tularensis genome sequence -- Genetic fingerprinting of biodefense pathogens for epidemiology and forensic investigation -- Yersinia pestis as an emerged pathogen: what lessons can be learned? -- Requirements for biological threat identification systems -- DNA-based diagnostic tests for detection and identification of biological weapons -- Concepts for the development of immunodiagnostic assays for detection and diagnosis of biothreat agents.
- Bioterrorism 2004, CRCnetBASE
- Bioterrorism and infectious agents 2009, SpringerAnthrax : a disease and a weapon / Kenneth Alibek, Catherine Lobanova and Serguei Popov -- Plague as a biological weapon / David T. Dennis -- Tularemia and bioterrorism / Lisa Hodges and Robert L. Penn -- Melioidosis and Glanders as possible biological weapons / David Allan Brett Dance -- Smallpox as a weapon for bioterrorism / J. Michael Lane -- Hemorrhagic Fever viruses as biological weapons / Allison Groseth ... [et al.] -- Botulism as a potential agent of bioterrorism / Thomas P. Bleck -- Ricin : a possible, noninfectious biological weapon / Maor Maman and Yoav Yehezkelli -- Bioterrorism alert for health care workers / Theodore J. Cieslak, George W. Christopher and Edward M. Eitzen -- The economics of planning and preparing for bioterrorism / Martin I. Meltzer.
- Bioterrorism and infectious agents 2005, SpringerAnthrax : a disease and a weapon / Kenneth Alibek, Catherine Lobanova and Serguei Popov -- Plague as a biological weapon / David T. Dennis -- Tularemia and bioterrorism / Lisa Hodges and Robert L. Penn -- Melioidosis and Glanders as possible biological weapons / David Allan Brett Dance -- Smallpox as a weapon for bioterrorism / J. Michael Lane -- Hemorrhagic Fever viruses as biological weapons / Allison Groseth ... [et al.] -- Botulism as a potential agent of bioterrorism / Thomas P. Bleck -- Ricin : a possible, noninfectious biological weapon / Maor Maman and Yoav Yehezkelli -- Bioterrorism alert for health care workers / Theodore J. Cieslak, George W. Christopher and Edward M. Eitzen -- The economics of planning and preparing for bioterrorism / Martin I. Meltzer.
- Birkhäuser Advances in infectious diseases 2005-, SpringerInfectious diseases remain a substantial drain on human well-being and economies despite the availability of modern drugs. New pathogens emerge and known pathogens change their geographical distribution and their susceptibility to the available drugs. An understanding of the structure and function of infectious disease pathogens is a major scientific challenge with important potential applications. This monograph series provides up-to-date information on the latest developments in infectious disease research. The multi-authored volumes cover basic biology and biochemistry of pathogens as well as applied medical aspects and implications for public health and policy.-- Excerpted from publisher notes.
- Brain immune system signal molecules in protection from aerobic and anaerobic infections 2012, SpringerThe Cytokine System --The Discovery of the Brain Immunomodulators --Brain Neuroendocrine Immune System: Neurosecretion of Interleukins and New Cytokines Produced by NSO and NPV of Hypothalamus --Antibacterial and Antiviral Activity of PRP-1 (Galarmin) and Some Immunological Mechanisms of its Action --Treatment and Prophylaxis of Anthrax by Galarmin: Receptor Tyrosine Kinases is a Target of Galarmin --Prophylaxis and Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection with Proline-Rich Polypeptides Galarmin and Its Structural Analogues in an Experimental Murine Model --Treatment of Clostridium Perfringens-induced Gas Gangrene by New Cytokines of Brain --Hypothalamic, Proline-Rich Polypeptide (Galarmin) has Protective and Immunogenic Activity on Experimental Mycobacterium Tuberculosis Infection --Brain-Bone Marrow Neurohumoral Axis: Galarmin Controls Differentiation, Proliferation and Mobilization of Bone Marrow Progenitor cells --Antioxidant-Antiradical and Electron Donating Function of Galarmin and Gx-NH2 --Discussion --Summary.
- Executive summary -- Report of the working-group meeting / Christos Louis and Bart G.J. Knols -- Review of previous applications of genetics to vector control / Chris F. Curtis -- Genomics and expected benefits for vector entomology / Christos Louis -- Genetic approaches for malaria control / Marcelo Jacobs-Lorena -- Current thoughts about the integration of field and laboratory sciences in genetic control of disease vectors / Thomas W. Scott -- Genetic approaches in Aedes aegypti for control of dengue: an overview / Kenneth Olson .... [et al.] -- Malaria and dengue vector biology and control in West and Central Africa / Didier Fontenille and Pierre Carnevale -- Malaria and dengue vector biology and control in Southern and Eastern Africa / Maureen Coetzee -- Malaria and dengue vector biology and control in Southeast Asia / Pattamaporn Kittayapong -- Malaria and dengue vector biology and control in Latin America / Mario H. Rodriguez -- Transition from the laboratory to the field and effective interplay / Christos Louis -- Evaluation of drive mechanisms (including transgenes and drivers) in different environmental conditions and genetic backgrounds / Anthony A. James ... [et al.] -- Tools for monitoring the genetic structure and stability of mosquito populations / Gregory C. Lanzaro, Sergey Nuzhdin and Frederic Tripet -- What are relevant assays for refractoriness / George K. Christophides ... [et al.] -- Fitness studies: developing a consensus methodology / Thomas W. Scott ... [et al.] --Mosquito mating behaviour / Willem Takken ... [et al.] -- Pathogen evolution issues in genetically modified mosquito vector strategies / Mario H. Rodriquez -- Models to investigate some issues regarding the feasibility of driving refractoriness genes into mosquito vector populations / Chris F. Curtis -- Identification and characterization of field sites for genetic control of disease vectors / Bart G.J. Knols and Hervé Bossin -- Application of genetically modified mosquitoes in national vector control programmes: thoughts on integrated control / Abraham Mnzava ... [et al.] -- Entomological correlates of epidemiological impacts: how do we know it is working? / Andrew Githeko -- Ethical, legal and social issues in the use of genetically modified vectors for disease control / Yeya T. Touré and Lucien Manga.
- Canine and feline infectious diseases 2014, ScienceDirectBasic principles in the diagnosis and management of small animal infection -- Laboratory diagnosis of canine and feline infectious diseases -- Isolation in cell culture -- Immunoassays -- Isolation and identification of aerobic and anaerobic bacteria -- Isolation and identification of fungi -- Nucleic acid detection assays -- Antiinfective therapy -- Principles of antiinfective therapy -- Antiviral and immunomodulatory drugs -- Antibacterial drugs -- Antifungal drugs -- Antiprotozoal drugs -- Basic principles for infection control -- Infection control programs for dogs and cats -- Immunization -- Major infectious diseases and their etiologic agents -- Viral diseases -- Rabies -- Canine parvovirus infections and other viral enteritides -- Canine distemper virus infection -- Canine herpesvirus infection -- Canine viral respiratory infections -- Infectious canine hepatitis -- Feline panleukopenia virus infection and other viral enteritides -- Feline coronavirus infection -- Feline immunodeficiency virus infection -- Feline leukemia virus infection -- Feline respiratory viral infections -- Feline poxvirus infections -- Pseudorabies -- Viral papillomatosis -- Vector-borne and other viral encephalitides -- Bacterial diseases -- Ehrlichiosis -- Anaplasmosis -- Rocky mountain spotted fever -- Salmon poisoning disease -- Coxiellosis and q fever -- Chlamydial infections -- Streptococcal and enterococcal infections -- Staphylococcus infections -- Gram-negative bacterial infections -- Anaerobic bacterial infections -- Bordetellosis -- Cell wall-deficient bacterial infections -- Mycoplasma infections -- Hemoplasma infections -- Actinomycosis -- Nocardiosis -- Mycobacterial infections -- Salmonellosis -- Enteric Escherichia coli infections -- Campylobacteriosis -- Enteric clostridial infections -- Gastric Helicobacter-like infections -- Leptospirosis -- Lyme borreliosis -- Bartonellosis -- Canine brucellosis -- Tetanus and botulism -- Yersinia pestis (plague) and other yersinioses -- Tularemia -- Bite and scratch wound infections -- Fungal and algal diseases -- Dermatophytosis -- Malassezia infections -- Blastomycosis -- Histoplasmosis -- Cryptococcosis -- Coccidioidomycosis -- Sporotrichosis -- Aspergillosis -- Rhinosporidiosis -- Candidiasis -- Miscellaneous fungal diseases -- Pythiosis, lagenidiosis, and zygomycosis -- Protothecosis -- Pneumocystosis -- Protozoal diseases -- Toxoplasmosis -- Neosporosis -- Leishmaniosis -- Babesiosis -- Cytauxzoonosis -- Canine and feline hepatozoonosis -- Trypanosomiasis -- Giardiasis -- Trichomoniasis -- Cryptosporidiosis -- Isosporiasis -- Miscellaneous protozoal diseases -- Infections of selected organ systems -- Pyoderma, otitis externa, and otitis media -- Osteomyelitis, discospondylitis, and infectious arthritis -- Infections of the cardiovascular system -- Bacterial bronchopneumonia and pyothorax -- Intra-abdominal infections -- Bacterial infections of the genitourinary tract -- Bacterial meningitis -- Vaccination schedules for dogs and cats.
- Challenges in infectious diseases 2013, Springer"This new volume ... aims to address demands and challenges that various infections present to the world at large ('global challenges'), such as the HIV pandemic, continuous threat of spreading common multiresistant pathogenic bacteria, multidrug and extensive drug-resistant tuberculosis, and the influence we can expect on these epidemics with global climate change and international urbanization ... Chapters on these various topics authored by world-renowned experts on these areas provide state-of-the-art reviews on epidemiology, biology, clinical aspects, prevention, current approaches to control, and prevention such as new vaccines, and reassessment of past and present methods are discussed"--Preface.
- Changing face of disease 2004, CRCnetBASEEmerging disease in the third epidemiological transition -- Life history perspectives on human disease -- The Evolution, transmission and geographic spread of infectious diseases in human populations: questions and models -- Genetic epidemiology of parasitic diseases -- Urban pollution, disease and the health of children -- Protecting pregnant women from malaria -- Interdisciplinary research on Schistosoma japonicum -- Unravelling gene-environment interactions in type 2 diabetes -- Investigating the "hidden" epidemic: sexual behaviour and representation of HIV/AIDS amongst business people and medical personnel in five Central and Eastern European nations -- The Evolution of disease and the devolution of health care for American Indians -- The Public's health: the changing role of public health -- Human behaviour and the changing pattern of disease.
- Chlamydia pneumoniae 2004, Springer1. Chlamydia pneumoniae: prospects and predictions for an emerging pathogen / Scot P. Ouellette and Gerald I. Byrne -- 2. Morphology of Chlamydia pneumoniae / Naoyuki Miyashita and Akira Matsumoto -- 3. Cell and molecular biology of Chlamydia pneumoniae / Gunn Christiansen, Brian Vandahl, and Svend Birkelund -- 4. Antibiotic susceptibility and treatment of Chlamydia pneumoniae infections / Margaret R. Hammerschlag -- 5. Pneumonia caused by Chlamydia pneumoniae / Francesco Blasi ... [et al.] -- 6. Chlamydia detection in blood / Yoshimasa Yamamoto -- 7. Chlamydia pneumoniae infection and diseases: imunity to Chlamydia pneumoniae / Heljä-Marja Surcel -- 8. Vaccines against Chlamydia pneumoniae: can they be made? / Martin E. Rottenberg, Antonio Gigliotti Rothfuchs, and Hans Wigzell -- 9. Chlamydia pneumoniae and atherosclerosis - an overview of the Association / Joseph Ngeh and Sandeep Gupta --10. The biology of Chlamydia pneumoniae in cardiovascular disease pathogenesis / Scot P. Ouellette ... [et al.] -- 11. Animal models of Chlamydia pneumoniae infection and atherosclerosis / Ignatius W. Fong -- 12. Antiinfective trials for the treatment of Chlamydia pneumoniae in coronary artery disease / Joseph B. Muhlestein -- 13. Chlamydia pneumoniae and myocarditis / Håkan G. Gnarpe and Judy A. Gnarpe -- 14. Chlamydia pneumoniae as a candidate pathogen in multiple sclerosis / Charles W. Stratton and Subramaniam Sriram -- 15. Chlamydia pneumoniae in the pathogenesis of Alzheimer's disease / Brian J. Balin ... [et al.] -- 16. Chlamydia pneumoniae and inflammatory arthritis / Judith A. Whittum-Hudson, H. Ralph Schumacher, and Alan P. Hudson -- 17. Role of Chlamydia pneumoniae as an inducer of asthma / David L. Hahn -- 18. Respiratory tract infections caused by C. pneumoniae in pediatric patients / Kazunobu Ouchi.
- Chlamydial infection 2013, KargerEpidemiology and prevention and control programs for chlamydia / C.L. Satterwhite, J.M. Douglas, Jr. -- Chlamydia trachomatis pathogenicity and disease / D. Dean -- Chlamydia trachomatis genome structure / T.E. Putman, D.D. Rockey -- Chlamydia trachomatis : molecular testing methods / C.A. Gaydos -- Treatment of chlamydia trachomatis infections / M.R. Hammerschlag -- The Immunologic Response to Urogenital Infection / R.M. Johnson, W. Geisler -- Chlamydia vaccine development / J.U. Igietseme, C.M. Black -- Maternal and infant chlamydia trachomatis infections / I.G.I.J.G. Rours, M.R. Hammerschlag -- Chlamydia trachomatis infection among sexual minorities / D. Singh, J.M. Marrazzo -- Lymphogranuloma venereum : a concise outline of an emerging infection among men who have sex with men / H.J.C. de Vries, S. Morré.
- Cholera outbreaks 2014, SpringerThe most feared attribute of the human pathogen Vibrio cholerae is its ability to cause outbreaks that spread like wildfire, completely overwhelming public health systems and causing widespread suffering and death. This volume starts with a description of the contrasting patterns of outbreaks caused by the classical and El Tor biotypes of V. cholerae. Subsequent chapters examine cholera outbreaks in detail, including possible sources of infection and molecular epidemiology on three different continents, the emergence of new clones through the bactericidal selection process of lytic cholera phages, the circulation and transmission of clones of the pathogen during outbreaks, and novel approaches to modeling cholera outbreaks. A further contribution deals with the application of the genomic sciences to trace the spread of cholera epidemics and how this information can be used to control cholera outbreaks. The book closes with an analysis of the potential use of killed oral cholera vaccines to stop the spread of cholera outbreaks.
- Clinical cases in primary immunodeficiency diseases 2012, SpringerPrimary immunodeficiency diseases (PIDs) are a heterogeneous group of inherited disorders characterized by different defects in the development and function of the immune system. These defects render patients susceptible to a variety of infectious diseases. Knowledge of normal immunity and specific warning signs and symptoms can help physicians to identify those children with underlying PIDs.This book aims to increase the clinical awareness and knowledge of practicing clinicians regarding the diagnosis and management of PIDs. In order to achieve this goal, about 90 cases drawn from real life are presented, along with approximately 300 related questions. The selected case reports are the result of the invaluable cooperation of more than 40 scientists in the field of immunodeficiency. They focus both on the presenting features of patients with PIDs and on the required further investigation and management. Although the case scenarios relate to real histories, some modifications have been made for educational purposes. Each of the numbered cases is followed by the questions, their answers, and additional discussion. Each question focuses on a particular aspect of the PID under consideration, and the topics covered include clinical diagnosis, laboratory findings, molecular mechanisms, and therapy.This practical, case-oriented book will be an invaluable source of guidance on the diagnosis and treatment of patients with PIDs and will be relevant for those working in a variety of specialties and subspecialties.
- Clinical use of anti-infective agents 2012, Springer
- CNS infections 2014, Springer"This clinically oriented book covers selected infections of the central nervous system which are of considerable current interest. Aspects that are less well documented, such as spinal cord infections, central nervous system infections in patients with cancer, tropical infections, healthcare-associated ventriculitis or meningitis, and immunological problems in the international traveler are also discussed, as these are all problems relevant to daily practice."--Publisher's website.
- Color atlas of herpetic eye diseases 2009, Springer
- Color atlas of infective endocarditis 2006, Springer
- Common cold 2009, Springer
- Community-acquired pneumonia 2007, SpringerDiagnosis and treatment of community acquired pneumonia - the German perspective -- Detection of respiratory bacterial pathogens -- Viral pathogens and epidemiology, detection, therapy and resistance -- Resistance in Streptococcus pneumoniae -- Influenza -- Pathogenesis of Chlamydophila pneumoniae infections - epidemiology, immunity, cell biology, virulence factors -- Legionnaires' disease and its agent Legionella pneumophila -- Pathogenesis of Streptococcus pneumoniae infections: adaptive immunity, innate immunity, cell biology, virulence factors -- Pathogenesis of Mycoplasma pneumoniae infections: adaptive immunity, innate immunity, cell biology, and virulence factors -- Community-acquired pneumonia: paving the way towards new vaccination concepts.
- Comparative hepatitis 2008, Springer
- Congenital and perinatal infections 2006, Springer
- Congenital cytomegalovirus infection 2011, Springer
- Cryptosporidium and cryptosporidiosis. 2nd ed. 2008, CRCnetBASEGeneral biology / Ronald Fayer -- Genomics / Jessica C. Kissinger -- Biochemistry / Guan Zhu -- Epidemiology / Gordon Nichols -- Molecular epidemiology / Lihua Xiao and Una M. Ryan -- Diagnostics / Huw Smith -- Immune responses / Vincent McDonald -- Clinical disease and pathology / Cirle Alcantara Warren and -- Richard l. Guerrant -- Prophylaxis and chemotherapy / Heather D. Stockdale, Jennifer A. Spencer, and Byron L. Blagburn -- Foodborne transmission / Ynes R. Ortega and Vitaliano A. Cama -- Waterborne: drinking water / Jennifer L. Clancy and Thomas M. Hargy -- Waterborne: recreational water / Michael Beach -- Waste management / Dwight D. Bowman -- Fish, amphibians and reptiles / Thaddeus Graczyk -- Birds / Una Ryan and Lihua Xiao -- Zoo and wild mammals / Olga Matos -- Companion animals / Mónica Santín and James M. Trout -- Livestock / Mónica Santín and James M. Trout -- Animal models / Saul Tzipori and Giovanni Widmer -- In vitro cultivation / Michael J. Arrowood.
- Current topics of infectious diseases in Japan and Asia 2010, SpringerFeatures of enteric infections in Asia -- Molecular epidemiology of vibrio cholerae and campylobacters isolated in Asian countries -- Diarrheal diseases and probiotics -- Dengue and chikungunya virus infection in Southeast Asia: active governmental intervention in Republic of Singapore -- Current global situation of tuberculosis, with a focus on Japan -- Tuberculosis among the poor -- The status and trends of HIV/AIDS epidemics in Asia and the Pacific -- Disease characteristics and treatment of 2009 H1N1 influenza -- Drug-resistant respiratory pathogens in Japan.
- Subcutaneous and deep mycoses -- Hyalohyphomycosis -- Superficial mycoses -- Algae -- Mycobacteria -- Viruses -- Rickettsiae -- Crusted scabies -- Protozoa -- Helminth -- Spirochete -- Gram-Positive bacteria -- Gram-negative bacteria -- Viral related malignancies -- Clues to the diagnosis of skin lesions in the immunocompromised host -- Differential diagnoses.
- Cytopathology of infectious diseases 2012, SpringerIntroduction -- Specimen Collection and Handling -- Host Reactions to Infection -- Microbiology -- Gynecological Infections -- Pulmonary Infections -- Gastrointestinal and Hepatobiliary Infections -- Urinary Tract Infections -- Central Nervous System Infections -- Hematologic Infections -- Breast, Skin, and Musculoskeletal Infections -- Head and Neck Infections -- Immunosuppressed Host -- Ancillary Investigations -- Mimics and Contaminants.
- Dengue. New ed. 2009, WHO"Since the second edition of Dengue haemorrhagic fever: diagnosis, treatment, prevention and control was published by the World Health Organization (WHO) in 1997, the magnitude of the dengue problem has increased dramatically and has extended geographically to many previously unaffected areas. It was then, and remains today, the most important arthropod-borne viral disease of humans. Activities undertaken by WHO regarding dengue are most recently guided at the global policy level by World Health Assembly resolution WHA55.17 (adopted by the Fifty-fifth World Health Assembly in 2002) and at the regional level by resolution CE140.R17 of the Pan American Sanitary Conference (2007), resolution WPR/RC59.R6 of the WHO Regional Committee for the Western Pacific (2008) and resolution SEA/RC61/R5 of the WHO Regional Committee for South-East Asia (2008). This new edition has been produced to make widely available to health practitioners, laboratory personnel, those involved in vector control and other public health officials, a concise source of information of worldwide relevance on dengue. The guidelines provide updated practical information on the clinical management and delivery of clinical services; vector management and delivery of vector control services; laboratory diagnosis and diagnostic tests; and surveillance, emergency preparedness and response. Looking ahead, some indications of new and promising avenues of research are also described. Additional and more detailed specific guidance on the various specialist areas related to dengue are available from other sources in WHO and elsewhere, some of which are cited in the references. The contributions of, and review by, many experts both within and outside WHO have facilitated the preparation of this publication through consultative and peer review processes. All contributors are gratefully acknowledged, a list of whom appears under "Acknowledgements". These guidelines are the result of collaboration between the WHO Department of Control Neglected Tropical Diseases, the WHO Department of Epidemic and Pandemic Alert and Response, and the Special Programme for Research and Training in Tropical Diseases. This publication is intended to contribute to prevention and control of the morbidity and mortality associated with dengue and to serve as an authoritative reference source for health workers and researchers. These guidelines are not intended to replace national guidelines but to assist in the development of national or regional guidelines. They are expected to remain valid for five years (until 2014), although developments in research could change their validity, since many aspects of the prevention and control of dengue are currently being investigated in a variety of studies. The guidelines contain the most up-to-date information at the time of writing. However, the results of studies are being published regularly and should be taken into account. To address this challenge, the guide is also available on the Internet and will be updated regularly by WHO." - p. v.
- Diagnosis and treatment of human mycoses 2007, SpringerPart I. Approach to patients. Approach to patients with suspected fungal infections / Clinton K. Murray and Duane R. Hospenthal -- Part II. Laboratory and radiological diagnosis. Basic mycology / Deanna A. Sutton -- Diagnostic histopathology / Michael B. Smith and Michael R. McGinnis -- Diagnostic immunology / Samit S. Desai and Brian Wong -- Diagnostic radiology / Maria Angela C. Hospenthal and Constanza J. Gutierrez -- Part III. Antifungal agents. Antifungal agents / Russel E. Lewis and Annette W. Fothergill -- Part IV. Mycoses. Cadidiasis / Jack D. Sobel -- Infection due to non-candidal yeasts /Jose A. Vazquez -- Aspergillosis / Helen W. Boucher and Thomas F. Patterson -- Hyalophomycosis infection due to hyaline moulds / Rhonda V. Fleming and Elias J. Anaissie -- Phaeohyphomycosis infection due to dark (dematiaceous) moulds / Sanjay G. Revankar -- Zygomycosis (mucormycosis) / Charalampos Antachopoulos, Juan C. Gea-Banacloche, and Thomas J. Walsh -- Pneumocystosis / Francis Gigliotti and Terry W. Wright -- Cryptococcosis / Mathee Chayakulkeeree and John R. Perfect -- Blastomycosis / Stanley W. Champan and Donna C. Sullivan -- Coccidioidomycosis / Royce H. Johnson and Chehla Baqi -- Histoplasmosis / L. Joseph Wheat and Nicholas G. Conger -- Paraccocidiodoycosis / Angela Restrepo, Angela M. Tobón, and Carlos A. Agudelo -- Sporotrichosis / Carol A. Kauffman -- Dermatophytosis (tinea) and other superficial fungal infections / Aditya K. Gupta and Elizabeth A. Cooper -- Subcutaneous fungal infections (chromoblastomycossi, mycetoma, and lobomycosis) / Michael B. Smith and Michael R. McGinnis
- Disease control priorities in developing countries. 2nd ed. 2006, NCBI Bookshelf
- Disinfection and decontamination 2007, CRCnetBASEPerspectives on infection challenges and solutions / Manivannan -- Sisyphus in the microbial world revisited : global governance, antimicrobial strategies, and humanity's health / Fidler -- The need for safer and better microbiocides for infection control / Sattar, Springthorpe -- Microbiological concerns in non-sterile manufacturing / Farrington, Polarine -- New technologies in disinfection and infection control / Ramirez -- Biocides : modes of action and mechanisms of resistance / McDonnell -- A pragmatic approach to judicious selection and proper use of disinfectant and antiseptic agents in healthcare setting / Suljagic -- Extended activity of healthcare antiseptic products / Newman, Kaiser -- Disinfectant rotation in a cleaning/disinfection program for cleanrooms and controlled environments / Sutton -- Reprocessing flexible endoscopes : origin of standards, overview of structure/function, and review of recent outbreaks / Antonucci, Williams, Robinson -- Microbiological testing of disinfectants and decontaminants for critical surfaces / Klein -- Regulatory constraints on disinfectants and decontamination / Sarli -- Biofilms : a summarized account and control strategies / Nandakumar, Sreekumari -- Consequences of biofilms on indwelling medical devices : costs and prevention / Thomas, Nakaishi, Corum -- Infection-resistant implantable devices : biofilm problems and design strategies / Smith, Perera -- Infections of intracardiac devices / Yesenosky ... [et al.] -- Intrauterine devices : infections and biofilms / Pereira, Pruthi -- Antimicrobial urinary catheters / Stickler, Sabbuba -- Risk factors for post-operative infectious complications after abdominal surgery / Pessaux, Lermite.
- Drug interactions in infectious diseases. 3rd ed. 2011, SpringerIntroduction to Drug-Drug Interactions -- Mechanisms of Drug Interactions I: Absorption, Metabolism, and Excretion -- Mechanisms of Drug Interactions II: Transport Proteins -- Drug-Food Interactions -- Interactions Between Herbs and Antiinfective Medications -- Drug-Cytokine Interactions -- Beta-Lactam Antibiotics -- Macrolides, Azalides, and Ketolides -- Quinolones -- Glycopeptides, Lipopeptides, and Lipoglycopeptides -- Miscellaneous Antibiotics -- Drugs for Tuberculosis -- Drug Interactions with Antiretrovirals for HIV Infection -- Non-HIV Antiviral Agents -- Antifungal Agents -- Antimalarial Agents -- Antiprotozoal and Anthelmintic Agents -- Drug Interaction Considerations Throughout Drug Development -- Probe Cocktail Studies -- Design and Data Analysis in Drug Interaction Studies.
- Dynamic modeling of diseases and pests 2009, SpringerThe why and how of dynamic modeling -- Basic epidemic models -- Insect dynamics -- Malaria and sickle cell anemia -- Encephalitis -- Chagas disease -- Lyme disease -- Chicken pox and shingles -- Toxoplasmosis -- The zebra mussel -- Biological control of pestilence -- Indirect susceptible-infected-resistant models of arboviral encephalitis transmission -- Chaos and pestilence -- Catastrophe and pestilence -- Spatial pestilence dynamics.
- This book covers modeling of insect vector-borne infectious diseases, which account for some three million deaths worldwide. The authors describe processes for quantifying the vital parameters of diseases transmitted by mosquitoes, sand flies, fleas and ticks. Despite great advances in public health worldwide, insect vector-borne infectious diseases remain a leading cause of morbidity and mortality. Diseases that are transmitted by arthropods such as mosquitoes, sand flies, fleas, and ticks affect hundreds of millions of people and account for nearly three million deaths all over the world. In the past there was very little hope of controlling the epidemics caused by these diseases, but modern advancements in science and technology are providing a variety of ways in which these diseases can be handled. Clearly, the process of transmission of an infectious disease is a nonlinear dynamic process which can be understood only by appropriately quantifying the vital parameters that govern these dynamics.
- Economics and preventing healthcare acquired infection 2009, Springer
- Chapter 1. Identifying general requirements -- Chapter 2. Identifying detailed requirements -- Chapter 3. Selecting a solution -- Chapter 4. Implementing an electronic recording and reporting system .
- Emergence of zoonotic diseases 2002, NAP
- Emerging and endemic pathogens 2010, SpringerGlobal effects and prevention of emerging and epidemic pathogens: cholera and citrus greening as examples -- Surveillance -- Epidemiological surveillance of highly pathogenic diseases in Kazakhstan -- Surveillance on plague in Natural foci in Georgia -- Application of modern techniques for studying bacterial pathogens in Georgia -- Especially dangerous infections in Azerbaijan -- Strengthening the early-warning function of the surveillance system: the Macedonian experience -- Integrating geographic information systems and ecological niche modeling into disease ecology: a case study of Bacillus anthracis in the United States and Mexico -- Molecular analysis and tools -- Applications of paleomicrobiology to the understanding of emerging and re-emerging infectious diseases -- Characterization of a putative hemagglutinin gene in the caprine model for brucellosis -- Pathoadaptation of especially dangerous pathogens -- Detection of pathogens via high-throughput sequencing -- Environmental infuences on the relative stability of baculoviruses and Vaccinia virus: a review.
- Emerging epidemics 2013, WileyA global perspective on the management and prevention of emerging and re-emerging diseases Emerging infectious diseases are newly identified or otherwise previously unknown infections that cause public health challenges. Re-emerging infectious diseases are due to both the reappearance of and an increase in the number of infections from a disease that is known, but which had formerly caused so few infections that it was no longer considered a public health problem. The factors that cause the emergence or re-emergence of a disease are diverse. This book takes a look at the worl
- Emerging foodborne pathogens 2006, CRCnetBASEpt. 1. Identifying emerging pathogens -- pt. 2. Individual pathogens.
- Emerging infections in Asia 2008, Springer
- Emerging viral diseases of Southeast Asia 2007, KargerThe Singapore contribution in the battle against the severe acute respiratory syndrome / Fielding, B.C., Tan, Y.-J. -- Avian influenza in Thailand / Puthavathana, P. ... [et al.] -- Emerging viral diseases of fish and shrimp / Wang, M. ... [et al.] -- Avian influenza H5N1 virus: an emerging global pandemic / Lal, S.K., Chow, V.T.K. -- Henipaviruses: new threats for Southeast Asia and Australia / McCormack, J., Smith, G. -- Ross River virus: an arthritogenic alphavirus of significant importance in the Asia Pacific / Tupanceska, D. ... [et al.] -- Emerging and re-emerging infectious diseases in our global village / Heymann, D.L. -- Role of a pathology laboratory in SARS and other emerging infections / Nicholls, J., Peiris, J.S.M. -- The fight against emerging viral diseases in Asia / Lam, S.K.
- Epidemic of medical errors and hospital-acquired infections 2012, CRCnetBASE"'Do no harm' a particularly leading and important phrase in the delivery of healthcare is not working. In fact depending on the epidemiological approach and which data sets one applies, medical errors, hospital acquired infections (HAIs) and pharmaceutical errors combined are the second or third leading killer of Americans annually: approximately 300,000 die from a combination of medical errors, hospital acquired infections (HAIs), and pharmaceutical errors...100,000 per category. Add to these numbers the hundreds of thousands who are harmed (morbidity) but not killed (mortality) changing quality of life and a substantial problem is defined"--Provided by publisher.
- Epidemiological and molecular aspects on cholera 2011, Springer
- Epidemiological odyssey 2012, Springer1.Early Concepts of Communicability --2.Infection on the Move --3.The Impact of Cholera --4.Stiffening the Sinews --5.Dawn and Sunset --6.A Need for Damage Limitation --7.No Lasting Stability --8.Tailpiece.
- Essential infectious disease topics for primary care 2008, SpringerPart I. Upper Respiratory Tract Infections -- 1. Clinical guidelines: community acquired pneumonia / John Russell -- 2. Pharyngitis / Adrian Wilson -- 3. Treatment and management of acute otitis media / Ross H. Albert and Neil S. Skolnik -- 4. Management of chronic obstructive pulmonary disease exacerbations and acute bronchitis / Michael Gagnon -- 5. Latent tuberculosis infection: testing and treatment / Pamela Ann Fenstemacher -- 6. Sinusitis / Megan Werner and Mathew Clark -- Part II. Gastrointestinal Infections -- 7. Gastroenteritis / Andrew Deroo and Matthew Mintz -- 8. Hepatitis / Michele Lamoreux -- III. Sexually Transmitted Diseases -- 9. Sexually transmitted diseases / Neil Skolnik -- 10. Human immunodeficiency virus / Rosemary Harris -- IV. Skin, Bone, and Joint Infection -- 11. Cellulitis and skin infections associated with bites / Steven Zinn and Judith O'Donnell -- 12. Diabetic foot infections / Thomas C. McGinley Jr. -- 13, Osteomyelitis / Kelly Gannon and Todd Braun -- 14. Septic arthritis and infectious bursitis / Gene Hong and Nirandra Mahamitra -- 15. Lyme disease prevention, diagnosis, and treatment / Ross Albert and Neil Skolnik -- V. Other Infectious Disease Topics -- 16. Infective endocarditis / Tina Degnan and Neil Skolnik -- 17. Meningitis / Anne T. Wiedemann -- 18. Urinary tract infections / Jennifer Neria and Matthew Mintz -- 19. Adult immunizations / John Russell and Ross Albert -- 20. Clinical ethics and infectious disease in family medicine / Janet Fleetwood.
- Evidence-based neonatal infections 2014, WileyHow to search for evidence -- Epidemiology -- Clinical manifestations -- Laboratory tests -- Rational antibiotic use -- Adjunctive treatment -- Bacterial meningitis -- Respiratory tract infections -- Osteomyelitis and septic arthritis -- Urinary tract infections -- Necrotizing enterocolitis and gastrointestinal infections -- Eye infections -- Skin and soft tissue infections -- Bacterial infections -- Mycoplasmas -- Fungal infections -- Viral infections -- Other congenital infections -- Breast milk -- Surveillance -- Infection control -- Developing countries -- Prevention of neonatal infections -- Neonatal antimicrobials.
- Foodborne disease outbreaks 2008, WHO"These guidelines have been written for public health practitioners, food and health inspectors, district and national medical officers, laboratory personnel and others who may undertake or participate in the investigation and control of foodborne disease outbreaks."--P. 4 of cover.
- Foodborne pathogens 2002, CRCnetBASE
- Foot and mouth disease 2003, Wellcome Trust
- Function and control of the Spx-family of proteins within the bacterial stress response 2013, SpringerThis SpringerBrief on Spx reviews the investigations that led to the discovery of Spx and its orthologs and ties together the results of various studies that have explored the function and control of spx in Gram-positive organisms. Spx of Bacillus subtilis has been extensively studied, but very little has been published about it. This book incorporates a number of studies that have been conducted in other Gram positive bacteria, which examined the role of Spx orthologs in stress response, bacterial development and virulence. The book contains an overview that will introduce the protein and its orthologous forms, its association with RNA polymerase, the species of Gram-positive bacteria in which it is found, and the conditions in which it is abundant and active. Spx is a member of a large group of proteins belonging to the ArsC/Spx protein family, so the review touches upon the bioinformatic support for the protein family composition and its meaning with regard to protein structure/function.
- Over the past decade, significant progress has been made in the theory and applications of pharmacodynamics of antimicrobial agents. On the basis of pharmacokinetic-pharmacodynamic modeling concepts it has become possible to describe and predict the time course of antimicrobial effects under normal and pathophysiological conditions. The study of pharmacokinetic-pharmacodynamic relationships can be of considerable value in understanding drug action, defining optimal dosing regimens, and in making predictions under new or changing pre-clinical and clinical circumstances. Not surprisingly, pharmacokinetic-pharmacodynamic modeling concepts are increasingly applied in both basic and clinical research as well as in drug development. Fundamentals of Antimicrobial Pharmacokinetics and Pharmacodynamics is designed as a reference on the application of pharmacokinetic-pharmacodynamic principles for the optimization of antimicrobial therapy, namely pharmacotherapy, and infectious diseases. The reader is introduced to various aspects of the fundamentals of antimicrobial pharmacodynamics, the integration of pharmacokinetics with pharmacodynamics for all major classes of antibiotics, from basic research to clinical situations.
- "This fourth volume of the Global Burden of Disease and Injuries Series provides the reader with information on the epidemiology and burden of major infectious and parasitic diseases. As with previous volumes of the Global Burden of Disease study, the chapters in this book detail the situation as experienced in the year 1990. Since then the epidemiology of some of the conditions described has changed, and where this is the case the authors have added a brief paragraph acknowledging this. The chapters therefore do not provide a detailed update on the current burden of disease, which is accommodated in the documentation of the Global Burden of Disease 2000 and published elsewhere."--Preface.
- "Using the two-page, templated organization of the 5-Minute Consult series, Gorbach's 5-Minute Infectious Diseases Consult, Second Edition provides comprehensive coverage for clinicians dealing with infectious diseases. The two major sections of the book cover chief complaints and individual diseases and disorders. Additional materials include summary information about individual microorganisms as well as numerous elements related to drugs for infectious disorders. A team of international authorities provides actionable information, supported by current research and practice guidelines.Features Include: Comprehensive coverage of infectious diseases, important symptoms, microorganisms, and anti-infective drugs Coverage of emerging infectious diseases such as H1N1 flu Increased coverage of tropical diseases Two-page, tightly written chapters Updated information about management of HIV/AIDS "--Provided by publisher.
- Grand challenge for the future 2005, Springer
- Handbook of media for clinical and public health microbiology 2014, CRCnetBASE"Preface Almost 1,800 media are described in the Handbook of Media for Clinical and Public Health Microbiology, including newly described media for the cultivation of emerging pathogens. Diseases caused by emerging pathogens that are responsible for increased rates of morbidity and mortality rates, such as Escherichia coli O157:H7, methicillin resistant Staphylococcus aureus (MRSA), vancomycin resistant enterococci (VRE), and carbapenem resistant enterococci (CRE) have raised special concerns and various media included in the Handbook have been designed for the specific cultivation and identification of these pathogens. Many of the new media included in the Handbook of Media for Clinical and Public Health Microbiology permit the cultivation of bacteria, fungi, and viruses that are currently causing major medical problems around the world. These media are very important for the rapid detection of pathogenic microorganisms and the diagnosis of individuals with specific infectious diseases adn for preventing the spread of pathogens via food, water, and environmental sources. Several of the new media described in the Handbook of Media for Clinical and Public Health Microbiology include chromogenic or fluorogenic substrates that permit the rapid detection of specific pathogens. An important function of the Handbook of Media for Clinical and Public Health Microbiology is to provide descriptions of the media that are used to cultivate and identify microorganisms from clinical specimens and those of public health significance. The Handbook provides a compilation of the formulations, methods of preparation, and applications for media used in clinical and public health microbiology laboratories"--Provided by publisher.
- HCV infection and cryoglobulinemia 2012, Springer
- Hematology, immunology and infectious disease. 2nd ed. 2012, ScienceDirect
- Herpes zoster 2006, kargerMolecular biology of varicella-zoster virus / Rahaus, M., Desloges, N., Wolff, M.H -- Latency and reactivation of VZV / Lungu, O., Gershon, A.A. -- Laboratory confirmation of herpes zoster / Ludwig, B., Buxbaum, S., Doerr, H.W. -- Clinical picture and complications of herpes zoster: the view of the dermatologist / Gross, G. -- Ophthalmic manifestations of herpes zoster infection / Guembel, H. -- (Herpes) zoster oticus / Pau, H.W. -- Neuroanatomy of pain and neuropathology of herpes zoster and postherpetic neuralgia / Wree, A., Usunoff, K.G. -- Postherpetic neuralgia and other neurologic complications / Baron, R. -- Varicella-zoster virus infections during pregnancy / Sauerbrei, A., Wutzler, P. -- Herpes zoster in the immunocompromised host / Schöfer, H. -- Chickenpox and zoster in marrow transplant recipients / Genvresse, I., Maschmeyer, G. -- General aspects of therapy / Gross, G. -- Antiviral therapy of shingles in dermatology / Lilie, H.M., Wassilew, S.W. -- Highly potent and selective inhibition of varicella-zoster virus replication by bicyclic furo[2,3-d] pyrimidine nucleoside analogues (BCNAS) / Clercq, E.D. -- Therapy of zoster pain, postherpetic neuralgia and other neurological complications / Baron, R. -- Epidemiology of herpes zoster: what has changed? / Allwinn, R., Buxbaum, S., Doerr, H.W. -- Live attenuated varicella vaccine / Gershon, A.A.
- Section I. Applied epidemiology and biostatistics in healthcare epidemiology and infection control -- Section II. Healthcare quality improvement -- Section III. Informatics in healthcare epidemiology -- Section IV. Epidemiology and prevention of healthcare-associated infections of organ systems -- Section V. Epidemiology and prevention of healthcare-associated infections caused by specific pathogens -- Section VI. Epidemiology and prevention of healthcare-associated infections in pediatric patients -- Section VII. Epidemiology and prevention of healthcare-associated infections in special patient populations -- Section VIII. Epidemiology and prevention of healthcare-associated infections related to diagnostic and therapeutic procedures -- Section IX. Prevention of healthcare-associated infections related to the hospital environment -- Section X. Epidemiology and prevention of healthcare-associated infections in healthcare workers -- Section XI. Disinfection and sterilization -- Section XII. Prevention of infectsions acquired by patients in healthcare facilities related to design, construction, renovation, demolition and ventilation systems -- Section XIII. Antimicrobial agents in healthcare epidemiology and infection control -- Section XIV. Literature in healthcare epidemiology and infection control -- Section XV. Organization and implementation of infection control programs -- Section XVI. Healthcare epidemiology and infection control in special settings for healthcare delivery -- Section XVII. Bioterrorism.
- Hospital infection prevention 2014, SpringerThe art of medicine becomes science when supported by evidence. The recommended practices of infection prevention are based on scientific and epidemiologic evidence. However,most health care professionals see them as mandates and fail to incorporate them into their routine patient care activities. Thecore goal of this publication is to link the practices to theprinciples they are based on. The expectation is that understanding ofthe principles willchange thepractices from mandates to "should do" in the minds of health care professionals. This will lead to improvement inhealth care by preventing unintended harm to patients, co-workers and the communities at large. At the same time, the text provides a comprehensive, thorough and up to date information on all aspects of infection prevention in a reader-friendly manner and therefore, will serve as a valuable reference.
- Hot topics in infection and immunity in children. V 2009, SpringerShiga-toxin producing escherichia coli and the hemolytic uremic syndrome / Christina K. Ahn, Nicholas J. Holt, Phillip I. Tarr -- Global epidemiology of pneumococcal disease - new prospects for vaccine control / Vinicius C. Antao, William P. Hausdorff -- Current concepts of the pathogenesis of RSV bronchiolitis / Louis Bont -- How can we eradicate pertussis / James D. Cherry -- Recognition and management of encephalitis in children / James D. Cherry -- Microbiology and management of pleural empyema / Julia Clark -- Pneumococcal conjugate vaccines probe studies / Ron Dagan -- New findings in primary immunodeficiency / Andrew R. Gennery, Andrew J. Cant -- Routine use of influenza vaccine / David Isaacs -- Challenges in the evaluation and management of bone and joint infections and the role of new antibiotics for gram positive infections / Sheldon L. Kaplan -- Significance of serotype replacement for pneumococcal disease and antibiotic resistance / Keith P. Klugman -- Childhood intra-thoracic tuberculosis / Ben J. Marais -- Antibiotic pipeline in pediatrics / George H. McCracken -- Paediatric drug development and clinical trials / E. David G. McIntosh -- Influenza in pregnancy / Shelly McNeil, Beth Halperin, Noni MacDonald -- Febrile neutropenia in children with cancer / Stéphane Paulus, Simon Dobson -- PANDAS syndrome / Michael E. Pichichero -- Fever in the returned paediatric traveller / F. Andrew I. Riordan -- Molecular diagnostics of primary immunodeficiencies / Mirjam van der Burg, Menno C. van Zelm, Jacques J.M. van Dongen -- Human genetic resistance to malaria / Thomas N. Williams.
- Human papillomavirus 2009, Springer
- Human papillomavirus 2014, Karger"Human papillomavirus (HPV) infection transcends multiple fields of science and medicine. The management of HPV-related disease is demanding and often requires a persistent multimodal approach involving various medical disciplines. In this volume, experts present a comprehensive view of HPV research with an emphasis on clinical presentations, diagnosis, management and vaccine development. The state of the art in molecular biology is provided in addition to discussions on clinical morphology and the utility of dermatoscopy in identifying HPV disease. In a multidisciplinary approach to dermatological, plastic and reconstructive, gynecological, otolaryngological and colorectal management, different treatment strategies are highlighted"--Publisher's description.
- Immunology and evolution of infectious disease 2002, NCBI Bookshelf
- Immunology and immunopathogenesis of malaria 2005, SpringerThe dissection of CD8 T cells during liver-stage infection / U. Krzych and R.J. Schwenk -- Early interactions between blood-stage Plasmodium parasites and the immune system / B.C. Urban, R. Ing, and M.M. Stevenson -- Longevity of the immune response and memory to blood-stage malaria infection / A.H. Achtman ... [et al.] -- Experimental models of cerebral malaria / C. Engwerda ... [et al.] -- Glycosylphosphatidylinositols in malaria pathogenesis and immunity : potential for therapeutic inhibition and vaccination / C.S. Boutlis ... [et al.] -- The immunology and pathogenesis of malaria during pregnancy / J.G. Beeson and P.E. Duffy.
- Immunology of fungal infections 2007, Springer
- Immunosenescence 2012, Springer
- In the blink of an eye 2013, Springer1. Origins -- 2. The Art and Science of Germs -- 3. A Singular Disease -- 4. A Very Mortal Disease -- 5. Early Approaches at Therapy -- 6. Antibiotics and Survival of the Fittest -- 7. A Brief History of Vaccines -- 8. That Soluble Specific Substance -- 9. Towards a Vaccine -- 10. Success for Half -- 11. The Future of a Killer.
- Infection and local treatment in orthopedic surgery 2007, Springer
- Infection control in the intensive care unit. 2nd ed. 2005, Springer
- Infection, immune homeostasis and immune privilege 2012, SpringerThe Eye as a model for immune privilege -- Immune privilege of the testis: meaning, mechanisms, and manifestations -- The Role of intrauterine immune privilege in perinatal infectious diseases -- The Liver as an immune-privileged site -- Immune homeostasis of the lung: the role of regulatory NKT cells in asthma -- Immune homeostasis of the gut.
- Infectious complications in cancer patients 2014, SpringerWhile advances in both the treatment of cancer and the management of its complications have led to significant improvement in patient survival, infections remain a significant cause of morbidity and mortality in patients with neoplastic disease. In this patient population, infection risk results from a complex interplay between the host's underlying immunodeficiencies, local tumor effects, and treatment-induced immunosuppression. New chemotherapeutic approaches and antimicrobial prophylaxis and treatment practices continue to shape the spectrum of infections in these patients. Clinicians who treat infections in cancer patients are continually challenged by the emergence of new pathogens and by the increasing antimicrobial resistance of established ones. The aim of this book, is to emphasize unique aspects of management of infectious diseases in the cancer patient. With the increasing complexity of this patient population, optimal management requires a multidisciplinary approach, and this fact is fully reflected in the contributions, all from recognized authorities in the field. Ultimately, it is hoped that this volume will assist specialists in infectious diseases and haematology/oncology in the diagnosis, management, and prevention of infection and optimization of the overall care of patients with malignancies.
- Infectious disease in the aging. 2nd ed. 2009, SpringerConcepts and principles of infections and aging -- Epidemiology of aging and infectious diseases -- Factors predisposing to infection -- Clinical features of infection -- Role and importance of functional assessment in infections -- Principles of antimicrobial therapy -- Common infections -- Sepsis -- Bronchitis and pneumonia -- Tuberculosis in older adults -- Infective endocarditis -- Intra-abdominal infections -- Infectious diarrhea -- Urinary tract infection -- Bacterial meningitis and brain abscess -- Osteomyelitis and septic arthritis -- Skin and soft tissues infections -- Herpes zoster -- Orofacial and odontogenic infections in the elderly -- Ocular infections -- Otitis externa, otitis media, and sinusitis -- Prosthetic joint infections in elderly patients -- Staphylococcal and enterococcal infections -- Fungal infections -- Viral infections -- Unique infectious disease problems -- Infections in the long-term care setting -- Infection control programs in nursing homes -- Infections in diabetes -- Vaccinations -- Nutrition and infection -- Sexually transmitted diseases -- Human immunodeficiency virus/acquired immunodeficiency syndrome -- SARS and West Nile virus.
- Infectious disease informatics 2010, SpringerInformatics for infectious disease research and control -- Bioinformatics of microbial sequences -- Mining databases for microbial gene sequences -- Comparative genomics of pathogens -- Systems microbiology: gaining insights in transcriptional networks -- Host-pathogen systems biology -- Text mining for discovery of host-pathogen interactions -- Network approach to understanding pathogen population structure -- Computational epitope mapping -- Pangenomic reverse vaccinology -- Immunoinformatics: the next step in vaccine design -- Understanding the shared bacterial genome -- Computational grammars for interrogation of genomes -- In silico discovery of chemotherapeutic agents -- Informatics for healthcare epidemiology -- Automated, high-throughput surveillance systems for public health -- Microbial genotyping systems for infection control -- Temporal and spatial clustering of bacterial genotypes -- Infectious disease ontology -- Populations, patients, germs and genes: ethics of genomics and informatics in communicable disease control.
- Infectious disease surveillance. 2nd ed. 2013, WileyThis fully updated edition of Infectious Disease Surveillance is for frontline public health practitioners, epidemiologists, and clinical microbiologists who are engaged in communicable disease control. It is also a foundational text for trainees in public health, applied epidemiology, postgraduate medicine and nursing programs. The second edition portrays both the conceptual framework and practical aspects of infectious disease surveillance. It is a comprehensive resource designed to improve the tracking of infectious diseases and to serve as a starting point in the developme.
- Infectious diseases 2013, SpringerInfectious Diseases: Selected Entries from the Encyclopedia of Sustainability Science and Technology presents authoritative, peer-reviewed contributions from leading experts on a wide range of major infectious diseases of global importance. Infectious diseases account for more than 17 million deaths each year worldwide. While modern medicine and technology have diminished the threat of many of these pathogens in high-income countries, the ever present threats of re-emerging infections, population mobility, natural disasters, and pathogen genetic variability are but some of the reasons for the dynamic threat of this broad category of risks to human health. An indispensable resource for students and scientists, the volume also covers some of the new technologies currently under development for infectious disease prevention, treatment, and eradication. The greater part of the infectious disease burden remains in the tropics, where low and middle-income countries lack the resources, infrastructure, and health systems to mount or sustain control efforts. Many contributions describe the efforts of the scientific research community and international donor agencies to achieve the integrated goals of vigilant surveillance, improved and cost-effective diagnostics, and treatment for sustainable disease control.Describes the dynamic nature of infectious disease agents and their complex interactions with the environment and their human and animal hosts Covers new technologies for antibiotics, vaccines, and treatment Features several contributions on waterborne infectious diseases, including enteric viruses and bacterial pathogens in the ocean Provides an excellent introduction for those entering the field, as well as new insights for advanced researchers and industry experts
- Infectious diseases and nanomedicine. I-II 2014, Springerv. 2 SpringerThe volumes address the interdisciplinary scientific approach for the systemic understanding of connections between major human diseases and their treatment regime by applying the tools and techniques of nanotechnology. It also highlights the interdisciplinary collaborative researches for innovation in Biomedical Sciences.
- Infectious diseases and substance abuse 2005, Springer
- Harrison's Principles of Internal Medicine
- AAP Red Book Online
- Robbins & Cotran Pathologic Basis of Disease
- Sabiston Textbook of Surgery
- Nelson's Textbook of Pediatrics
- Surgical Exposures in Orthopaedics
- Mandell, Douglas, & Bennett's Principles & Practice of Infectious Diseases
- Red Book Online
- ICU Book
- Primary Care Medicine
- Campbell-Walsh Urology
Shortcut to Licensed Content
Bookmark on other websites
- Select "Add to Favorites" (click “Continue” if you see a security alert)
- From the "Create in" menu, select “Links” (IE7) or “Favorites Bar” (IE8, IE9) to install
- Once installed it will look like this
- Click "Bookmark on Lane" to bookmark any webpage
- Your saved bookmark will appear on this page
What is it?
This shortcut (Lane proxy bookmarklet) gives you access to resources licensed by the library even when you're not coming from a Lane or a Stanford IP address.
While we'd like Lane to be your gateway to our licensed content, we recognize that links to books, articles and journals come from a variety of different sources (Google, your email, RSS reader, etc.).
When installed, it will look your browser bookmark.
At the page you would like to proxy, click the "Lane Gateway to Licensed Content" to invoke it.
If Lane licenses that content, you'll get access as if you were on campus.
How does it work?
This allows you to view the URL as though you were on campus, giving you access to materials licensed for use by the Stanford academic community.
If you're not authenticated, you'll be prompted for your SUNetID and password.
Don't see the Toolbar, Bookmarks, or Links or Favorites bar?
From the "View" menu, select "Toolbars" & choose "Bookmarks Toolbar"
From the "View" menu, choose "Show Bookmarks Bar"
From the "View" menu, choose "Always Show Bookmarks Bar"
- Right-click in a clear area near the browser address bar
- In the menu, check a box next "Links" (IE7) or "Favorites" (IE8, IE9)
- Managing IE Favorites
This shortcut (Lane proxy bookmarklet) only works with resources Lane has licensed and configured to work with our proxy server.
If invoked on a resource we do not license and/or have not yet configured, you will see an error message:
The Lane proxy server cannot complete your request because this host has not been configured properly.
We make no attempt to configure our proxy server for every resource, only those we license and for which a Stanford IP address grants access.
Drag this button onto your browser toolbar to install.
- Right click this button
- Select "Add to Favorites", click "Continue" if you see a security alert
- In "Create in" menu, select "Links" (IE7) or "Favorites Bar" (IE8, IE9) to install
Drag this button onto Safari Bookmarks bar to install.
- Springer Protocols
- MD Consult
- Lange Series
- National Academy Press
- NCBI Bookshelf
- Thieme Atlases